Antitumor‐specific T‐cell responses induced by oncolytic adenovirus ONCOS‐102 (AdV5/3‐D24‐GM‐CSF) in peritoneal mesothelioma mouse model

Oncolytic adenoviral immunotherapy activates the innate immune system with subsequent induction of adaptive tumor‐specific immune responses to fight cancer. Hence, oncolytic viruses do not only eradicate cancer cells by direct lysis, but also generate antitumor immune response, allowing for long‐las...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuryk, Lukasz, Møller, Anne‐Sophie W., Garofalo, Mariangela, Cerullo, Vincenzo, Pesonen, Sari, Alemany, Ramon, Jaderberg, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120454/
https://www.ncbi.nlm.nih.gov/pubmed/29797583
http://dx.doi.org/10.1002/jmv.25229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120454/
https://www.ncbi.nlm.nih.gov/pubmed/29797583
http://dx.doi.org/10.1002/jmv.25229

Ejemplares similares